Full length cDNAs for p53 were made by reverse transcription-polymerase chain reaction of total RNA from two normal woodchuck livers. Two randomly chosen clones from each liver were sequenced and shown to be identical. This sequence revealed 80% or more identity with p53 sequences from human, monkey, and mouse. The cDNA was translated into a *55 kD protein in vitro that was immunoprecipitated by antibodies to p53. Cotranslation of woodchuck p53 with woodchuck hepatitis virus X antigen, followed by immunoprecipitation suggested X/p53 complex formation. Similar complexes were also immunoprecipitated from extracts of infected liver, but not from uninfected liver. The ®nding of X/p53 complexes in vivo and in vitro in the woodchuck hepadnavirus system, combined with analogous data with hepatitis B, suggests a common mechanism by which these viruses contribute to hepatocellular transformation.
Introduction
Woodchuck hepatitis virus (WHV) is closely related to hepatitis B virus (HBV) in its ultrastructure, genetic organization and replication (Summers et al., 1978; Summers, 1981) . Infection with these viruses is closely associated with the development of chronic hepatitis and hepatocellular carcinoma (HCC) (Robinson, 1994) . However, the underlying mechanism(s) associated with liver cell transformation remain to be clearly identi®ed. While cis-activation of N-myc and c-myc oncogenes by WHV promoter-insertion is a common feature of many HCCs among woodchucks (Moroy et al., 1986; Hsu et al., 1988; Fourel et al., 1990) , similar alterations of these genes in HBV associated hepatocarcinogenesis is lacking (Lee et al., 1988) . Instead, HBV DNA has been shown to be integrated at many dierent sites in the human genome (Matsubara and Tokino, 1990) . While most of these sites are not within or near known genes, integration events have been reported to occur near genes encoding V-erb-A, cyclin A, or the retinoic acid receptor (Dejean et al., 1986; Benbrook et al., 1988; Wang et al., 1992) . Integration in or around the locus encoding the tumor suppressor protein, p53, is frequently accompanied by allelic loss in HBV infection (Zhou et al., 1988) , but this has not yet been reported to be a feature of WHV associated carcinogenesis. Point mutations in p53 also appear to be rare in hepatocellular carcinomas associated with chronic hepadnavirus infections of ground squirrels and woodchucks (Rivkina et al., 1994) . In addition, although p53 mutations have been found in human HCCs, especially in those from areas of the world with known high a¯atoxin exposure (Bressac et al., 1991; Hsu et al., 1991) , such mutations appear to be a late event in the pathogenesis of this tumor type (Murakamai et al., 1991) . Hence the weight of evidence does not identify similarities in the mechanism of hepatocellular transformation based upon cisacting mechanisms.
Numerous observations suggest that the hepatitis B6antigen (HB6Ag) may play important roles in the pathogenesis of HCC. For example, HB6Ag expression is sustained at high levels in chronic carriers who develop HCC, and in many cases, it is the only HBV encoded product detected by immunohistochemistry 1991a) . Further, HB6Ag causes tumorigenic transformation of NIH3T3 cells (Shirakata et al., 1989) , and of an untransformed mouse hepatocyte cell line (Hohne et al., 1990) . More recently, HB6Ag has been shown to complex with and inactivate p53 both in vitro and in vivo (Feitelson et al., 1993a; Wang et al., 1994; Truant et al., 1995) , suggesting that this relationship may be important for tumor development. In addition, X transgenic mice which express sustained high levels of HB6Ag also develop tumors (Koike et al., 1994; Ueda et al., 1995) , while X transgenic mice which demonstrate an age related decrease in HB6Ag expression do not (Lee et al., 1990) . Further examination of the transgenic mice which develop tumors by immunohistochemical staining and immunoprecipitation have shown both costaining and coimmunoprecipitation of HB6Ag with wild type p53 (Ueda et al., 1995) . Given this evidence, experiments were designed to test the hypothesis that the woodchuck hepatitis6antigen (WH6Ag) also binds p53 both in vivo and in vitro, in order to see whether a common denominator is likely to contribute to hepatocellular transformation among these hepadaviruses.
Results
Primary and secondary structural features of the cDNA encoding the woodchuck liver p53 relative to p53 molecules from other selected mammalian species
Two putative p53 clones from each of two normal woodchuck livers were completely sequenced. The results obtained were con®rmed by independent sequencing of individual DNA strands from each clone, and the resultant sequences in all cases were in complete agreement. Figure 1 shows the complete nucleotide and deduced amino acid sequence of putative woodchuck p53. The cDNA is characterized by a single open reading frame of 1176 bases, which potentially encodes a polypeptide of 391 amino acids, with a calculated molecular weight of *44 kD. This clone is very similar in size and coding capacity to full length p53 from other mammalian species following alignment of the corresponding p53 sequences obtained from the GenEMBL and PIR databases (Figure 2 ). The woodchuck liver derived clones have a p53 consensus binding site AAACTGGTTT (spanning bases 153 ± 162) containing one mismatch at base 158 and several NF-b enhancer half-sites which are conserved in other mammalian p53s. The transcriptional activation domain of p53, which spans roughly the amino-terminal 50 residues, shows 68 ± 88% Figure 1 Nucleotide and deduced amino acid sequence of the cDNA encoding woodchuck liver p53. The nucleotide sequence (top row) was determined as described under Materials and methods. The deduced amino acid sequence is shown in single letter code below the corresponding codon. The p53 consensus binding site (line over nucleotide sequence) and the NFk-b half-sites (double underline under nucleotide bases) are indicated. The termination codon is indicated by an asterisk X/p53 interaction in WHV infection MA Feitelson et al homology with aligned regions from the other mammalian p53s (Figure 2 ). In comparison, the carboxy-terminal 100 amino acid residues of woodchuck p53, which encodes the putative oligomerization domain, was 80 ± 92% homologous with the analogous regions of the other mammalian p53s. The central core domain, roughly spanning residues 100 ± 300, was 90 ± 96% conserved, suggesting relatively little variation in this region, which is responsible for recognition and binding to speci®c DNA sequences. Although woodchuck p53 has an apparent deletion of two amino acids at positions 58 and 59, there were only 12 amino acid residues in woodchuck p53 which were not present in the alignment of all the other p53 molecules in which § Figure 2 Computer assisted alignment of amino acid sequences of woodchuck, human, monkey, and mouse p53 proteins. Monkey, human, and mouse p53 sequences were obtained from the GenEMBL database and aligned with the deduced amino acid sequence of woodchuck p53 using the pileup program of GCG. Gaps (.) were introduced to maximize regions of alignment. comparisons were made (Figure 2 ). Six of these dierences, however, represent conservative replacements between the woodchuck and at least one other p53 sequence. Another nine amino acid residues in woodchuck p53 show identity with the corresponding amino acid residue in one other p53 sequence. Further, the putative woodchuck p53 sequence presented here exhibited 499% homology with a partial p53 sequence comprising exons 4-9 from woodchuck liver (Rivkina et al., 1994) . Residues known to be susceptible to mutation in human tumor-derived samples were of wild type sequence in the woodchuck sequence. Hence, there is extensive amino acid homology (497%) among the clones isolated from woodchuck livers and the authentic p53 clones from other vertebrates, including man. Together, these features strongly suggest that the identity of the cDNA sequence is that of woodchuck p53. The similarities between woodchuck and human p53 molecules extend to the level of secondary protein structure. For example, when the number and position of putative a-helicies, b-sheets, and turns were compared, most of these features were highly conserved throughout the length of these molecules (Figure 3 ). Within the highly conserved`core' region, the woodchuck sequence had an extra a-helix, and in its place the human molecule had a region suggestive of b-sheet structure within the region spanning amino acids 200 ± 220 (Figure 3 ). Three sites in the less conserved amino-terminal region, and an additional three sites in the less conserved carboxy-terminal region (arrowheads), also showed variation among these molecules. However, a putative carboxy-terminal ahelix spanning residues 333 ± 365, and a basic region between 361 ± 385, both of which are functionally important (Figures 2 and 3) , are conserved among woodchuck and human p53s. Hence, these molecules have numerous similarities in both primary and secondary structures.
In vitro expression and association of woodchuck p53 and WHxAg
The ability of woodchuck p53 cDNA (pCITE-WCp53) to encode the corresponding protein was determined by in vitro transcription and translation. In vitro translation in the presence of [ 35 S]methionine resulted in the appearance of the expected polypeptide (Figure 4a , lane 1) at the apparent molecular weight of *55 kDa, and sometimes, one or more minor components were observed. These bands were not observed when the translation was carried out in the absence of pCITEWCp53 RNA (Figure 4a, lane 2) . A doublet of p53 (e.g., Figure 4a , lane 1), which is known to be associated with dierent phosphorylated forms (Ullrich et al., 1992) , may partially explain these ®ndings. Internal initiation, degradation, and/or aggregation of smaller products may also result in more than one band from a translation reaction. In addition, the dierences in the molecular weight values from SDS ± PAGE (55 kDa) compared to that deduced from the cDNA sequence (44 kDa) may be partially due to the high proline content (42 residues) in woodchuck p53. Human and mouse p53 molecules are also characterized by high proline content, accounting for 45 and 38 of their residues, respectively ( Figure 2 ). The ®nding that the putative p53 translation products are immunoprecipitated by anti-p53 ( Figure 4b , lane 3), but not by an irrelevant monoclonal antibody (anti-x) (lane 7, Figure  4b ), provides additional evidence that the in vitro translated products are p53. Collectively, these observations support the conclusion that the cDNA cloned and expressed represents the tumor suppressor product, p53, from normal woodchuck liver. Figure 4b ). The likely reasons for the heterogeneity in the WHxAg translation products are similar to some of those outlined above for p53. These translation products were immunoprecipitated with a well characterized anti-x monoclonal antibody (WC-9-85) (Figure 4b , lane 2), but not appreciably with an irrelevant monoclonal antibody (anti-p53) ( Figure 4b , lane 6), suggesting that the translation products corresponded to WHxAg polypeptides.
To test whether WHxAg and woodchuck p53 formed complexes in vitro, the polypeptides were cotranslated and then immunoprecipitated with anti-x (WC-9-85) or anti-p53 (PAb 240), and the products analysed by SDS ± PAGE (Figure 4b ). WHxAg was immunoprecipitated with anti-p53 in the presence of woodchuck p53 (lane 4), but not from lysates which were not programmed with pCITE-WCp53 RNA (lane 6). Likewise, woodchuck p53 was coimmunoprecipitated with anti-x in the presence of WHxAg (lane 1), but not from lysates which were not programmed with pCITE-WHx RNA (lane 7). When the immunoprecipitation was carried out in the absence of antibody, no products were seen (lane 5), suggesting that the complexes alone were not nonspeci®cally aggregated and collected by centrifugation. The speci®city of binding was further documented by the ®nding that the immunoprecipitation of WHxAg/p53 complexes with monoclonal anti-x (Figure 4c , lane 1) was mostly blocked in the presence of an excess (50 mg) of X antigen synthetic peptide previously identi®ed as the binding sequence of the monoclonal anti-x (lane 3) . Immunoprecipitation with an irrelevant IgM monoclonal antibody in place of WC-9-85 (an IgM) was also unsuccessful (Figure 4c, lane 4) , suggesting that the complexes were not nonspeci®cally trapped by IgM. Likewise, the ®nding that the immunoprecipitation of WHxAg/p53 complexes with monoclonal anti-p53 (Figure 4d , lane 1) was greatly reduced in the presence of an irrelevant monoclonal IgG (lane 2), and was mostly blocked by preincubation with an excess (50 mg) of p53 synthetic peptide which 
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anti-p53 pept 240 lgG MoAb binds to PAb 240 (lane 3), suggests that the binding of these complexes to PAb 240 is speci®c and that such complexes do not bind nonspeci®cally to the protein-G beads used in the immunoprecipitation protocol. Preincubation of WC-9-85 with the PAb 240 binding synthetic peptide, and preincubation of PAb 240 with the WC-9-85 binding synthetic peptide, did not reduce the amount of immunoprecipitated material in either case (data not shown). These combined results suggest that WHxAg and woodchuck p53 form complexes which are speci®cally detected by immunoprecipitation in vitro using antibodies directed against either component.
Given that the intensity of the bands which resulted from immunoprecipitation varied with the dierent antibodies and immunoprecipitation conditions used (Figure 4b ± d) , experiments were designed to determine the fractions of WHxAg and woodchuck p53 in complex formation. Accordingly, equal amounts of radiolabeled translation mixture containing WHxAg and woodchuck p53 were mixed and incubated overnight. The mixture was then divided in half with one half immunoprecipitated with anti-x and the other half immunoprecipitated with anti-p53. The results are presented in Figure 4e . As expected, both anti-x (WC-9-85) (lane 1) and anti-p53 (PAb 240) (lane 4) immunoprecipitated both polypeptides. When the supernatants from each were immunoprecipitated again with the same antibodies, anti-x did not bring down any further complexes (lane 2) while anti-p53 did (lane 5). When the supernatant resulting from the secondary immunoprecipitation with anti-x was immunoprecipitated again using anti-p53 instead, additional p53 and a trace of WHxAg was observed, suggesting that some complexes were still present (lane 3). The supernatant resulting from this step had only background counts and was not further analysed. Alternatively, when the supernatant resulting from the secondary immunoprecipitation with anti-p53 was again immunoprecipitated with anti-x, no bands were observed (lane 6). Together, these results suggest that virtually all of the WHxAg is complexed (compare lanes 1, 2 and 6), but that some of the woodchuck p53 may remain free (lane 3) under the immunoprecipitation conditions used. Alternatively, or in addition, the WHxAg associated with woodchuck p53 in lane 3 may not have been recognizable by anti-x (lane 2), suggesting that most or all of the p53 is tied up in at least two dierent types of complexes with WHxAg. This is also implied by the dierent relative intensities (re¯ecting dierent stoichiometries?) of the WHxAg and woodchuck p53 in lane 3 compared to lane 1. The ®nding that most or all of WHxAg and woodchuck p53 are complexed is analogous to earlier observations demonstrating that all of the detectable HBxAg and p53 from X transgenic mouse livers are also complexed (Ueda et al., 1995) .
Association of woodchuck p53 and WHxAg in cultured liver cells
Experiments were conducted to test the hypothesis that WHxAg and woodchuck p53 formed complexes in cultured hepatoma cells. Accordingly, the p53 null human hepatoma cell line, Hep 3B, was transiently transfected with pcDNA3-WHx and pcDNA3-p53, the cells radiolabeled with [ Cells which were transfected with pcDNA3 vector, radiolabeled, and immunoprecipitated with anti-X or anti-p53 did not yield bands which comigrated with WHxAg or woodchuck p53, respectively (data not shown). These results further support the hypothesis that WHxAg complexes to woodchuck p53 in liver cells. While some of the additional bands in lanes 3, 5 and 6 may be cellular polypeptides which become trapped in the immunoprecipitates, some may also correspond to other cellular proteins which bind to HBxAg and/or p53 (Cheong et al., 1995; Haviv et al., 1996; Huang et al., 1996; Lee et al., 1995; Macguire et al., 1991; Qadri et al., 1995; Levine, 1990; Hainaut and Milner, 1992; Seto et al., 1992; Momand et al., 1992; Zauberman et al., 1995) .
Complex formation between woodchuck p53 and WHxAg in liver and tumor tissues
To test whether the WHxAg/p53 complexes observed in vitro also exist in vivo, crude extracts prepared from Immunoprecipitates were analysed by SDS ± PAGE and the results revealed by autoradiography. An irrelevant mouse monoclonal IgG or IgM was used for immunoprecipitation in place of anti-p53 and anti-x, in lanes 7 and 8, respectively frozen liver and tumor tissue samples of WHV infected animals were immunoprecipitated with anti-p53 (PAb 240) or anti-x (Feitelson et al., 1993a) , and the results revealed by Western blotting. Initially, liver and tumor tissue samples from three WHV carrier animals were screened for the presence of WHxAg polypeptide by immunoprecipitation with anti-x (WC-9-85) (Feitelson et al., , 1993 and Western blotting with well characterized rabbit anti-x peptide antibodies . Two of the animals screened positive for the 17 kDa band. Examples of results from infected and uninfected livers are shown in lanes 1 ± 3 of Figure 6a . When samples were immunoprecipitated with anti-p53 and Western blotted with anti-x peptide antibodies, a 17 kDa band was also identi®ed in infected but not uninfected liver samples (lanes 4 ± 7). In reciprocal experiments, immunoprecipitation with anti-rWHx (Feitelson et al., 1993a) followed by Western blotting with anti-p53 resulted in the detection of an immunoreactive band at *53 kDa only in infected liver samples (Figure 6b , lanes 2 ± 5). This comigrated with a band resolved from homogenates of uninfected liver which was identi®ed by Western blotting using anti-p53 (lane 1). As in in vitro translation, the doublet of p53 sometimes seen in these samples may also re¯ect polypeptide heterogeneity, possibly associated with dierent phosphorylation states. Regardless of the source of heterogeneity, these results strongly suggest that WHxAg and woodchuck p53 form complexes in vivo. Combined with the in vitro results, the ®nding of WHxAg/p53 complex formation in vivo implies that they contribute to the pathogenesis of HCC in these animals.
Discussion
The fact that HBV and WHV are closely related viruses that share many physical, chemical, and biological properties, implies that they may also share common steps in the pathogenesis of HCC. The fact that HBxAg and WHxAg are also structurally and functionally similar (Galibert et al., 1982) , as are both human and woodchuck p53s, further suggests that they may share common properties, possibly including some of the mechanistic steps whereby these viruses mediate hepatocellular transformation. Given the increasing importance of HBxAg to transformation 1994; Shirakata et al., 1989; Hohne et al., 1990; Koike et al., 1994) , combined with its complexing to wild type p53 (Feitelson et al., 1993a; Ueda et al., 1995; Truant et al., 1995) , it was of great interest to see whether this also occurred in the WHV system. The results of this study show that WHxAg and woodchuck p53 form complexes both in vitro and in vivo in a manner analogous to that which occurs in human carriers with HCC, providing at least part of a common mechanism whereby these viruses cause hepatocellular carcinoma.
The focus on the X antigen of hepadnaviruses as being important to hepatocellular transformation comes from several lines of evidence. The overexpression of HBxAg transcripts in chronically infected patients with liver disease (Diamantis et al., 1992; Paterlini et al., 1995) , combined with the persistence of HBxAg in the livers of most HBV carriers with chronic liver diseases, including HCC 1991a) , suggest that persistently high levels of HBxAg in the liver accompany the development of this tumor type. The ®nding that HBxAg is often expressed from viral DNA fragments integrated into human liver or HCC nodules, and that the HBxAg made is still capable of trans-activation (Zahm et al., 1988; Wollersheim et al., 1988) , suggest that functional HBxAg is associated with the development of these tumors, although it is not known whether HBxAg associated trans-activation is relevant to hepatocarcinogenesis. In addition, the ®nding that HBxAg transforms NIH3T3 cells (Shirakata et al., 1989 ) and a nontransformed mouse hepatocyte cell line (Hohne et al., 1990) , suggests that under selected conditions, HBxAg can mediate transformation of cultured cells. Further, the ®nding that HBxAg complexes with the tumor suppressor product, p53, in the majority of HBV associated HCC Figure 6 Complex formation between woodchuck p53 and WHxAg in vivo. Crude extracts were prepared from frozen normal or infected livers for immunoprecipitation. (a) Homogenates were immunoprecipitated with anti-x (WC-9-85) and Western blotted with a mixture of three anti-x peptide antibodies ) from uninfected (lanes 1 and 2) or infected (lane 3) animals. Anti-p53 was used for immunoprecipitation of homogenates from two infected livers (lanes 4 and 5) or from two uninfected livers (lanes 6 and 7), followed by Western blotting with anti-x peptide antibodies. (b) Homogenates of uninfected liver were analysed by SDS ± PAGE and Western blotted with anti-p53 (lane 1). Liver homogenates from two infected (lanes 2 and 4) and two uninfected (lanes 3 and 5) animals were immunoprecipitated with anti-rWHx (Feitelson et al., 1993) and Western blotted with anti-p53 examined (Feitelson et al., 1993a) is consistent with the hypothesis that such complexes are important to the development of these tumors. The demonstration that HBxAg complexes with p53 in X antigen transgenic mice that develop liver tumors (Ueda et al., 1995; Koike et al., 1994) , combined with independent evidence showing that HBxAg may inhibit p53 transactivation function (Truant et al., 1995; Wang et al., 1994) , suggest that HBxAg inactivation of p53 may contribute to the appearance of HCC. However, the recently reported separation of p53 associated trans-activation from tumor suppressor properties (Hansen and Braithwaite, 1996) , combined with the ®nding that some p53 mutants are transcriptionally active but do not suppress transformation (Crook et al., 1994) , raises the question as to whether the inactivation of p53 trans-activation function by X antigen is relevant to hepatocarcinogenesis. Regardless of the mechanistic details, HBV may mediate transformation in ways which are similar to those of other DNA tumor viruses. The limited availability of human liver and tumor tissue to study the mechanism(s) of hepatocarcinogenesis has prompted the development of other naturally occurring or experimentally induced models of hepadnavirus associated HCC. The most popular naturally occurring model is the WHV infected woodchuck, in which up to 100% of carriers with chronic hepatitis develop tumors within 2 ± 3 years (Summers et al., 1978; Popper et al., 1987) . Mechanistic studies of hepatocarcinogenesis have revealed that the rearrangement and enhanced expression of N-myc associated with WHV DNA insertion-promotion, strongly correlates with tumor formation in these animals (Moroy et al., 1986; Hsu et al., 1988; Fourel et al., 1990) . However, the absence of HBV DNA integrated in or around the c-myc or N-myc loci, combined with the lack of enhanced myc expression in human tumors (Lee et al., 1988) suggests that this is not a common mechanism in human HCC. Given that HBxAg appears to stimulate the cell cycle of transiently transfected liver cells (Benn and Schneider, 1995) , the lack of p53 associated G1 checkpoint control (due to inactivation by HBxAg) may provide the environment whereby hepatocytes respond differently to signals regulating cell growth. For example, the recent ®nding that IgF II may overcome N-myc mediated apoptosis through signal transduction pathways, which may overlap or crosstalk with those stimulated by HBxAg (Ueda and Ganem, 1996; Su et al., 1994; Natoli et al., 1994) , suggests that suciently high levels of sustained HBxAg expression may short circuit growth regulatory pathways that usually return liver cells to quiescence following a bout of liver disease and regeneration. In this light, the ®nding that WHxAg forms complexes with woodchuck p53 in vitro and in vivo not only parallels the previous observations of HBxAg/p53 complex formation in human disease (Feitelson et al., 1993a) , but also provides a common denominator from which the mechanism(s) of HCC in humans can be further exploited using the woodchuck model. Studies are now underway to identify how WHxAg transforms liver cells, so that the relationship between the various functions of X antigen and p53 in relationship to hepatocellular transformation could be discerned.
Materials and methods
Cloning and sequencing of the full-length woodchuck p53 cDNA from liver Total RNA was isolated from snap frozen samples of two normal woodchuck livers (kindly supplied by Dr. Bud Tennant) using guanidinium chloride (Chirgwin et al., 1979) . Brie¯y, ®rst strand synthesis was carried out by reverse transcription with avian myeloblastosis virus reverse transcriptase (RT) (Promega, Madison, WI) for 1 h at 428C in the presence of an oligo dT primer, in order to generate single stranded DNAs enriched from poly(A) + RNA. The latter served as templates for subsequent PCR with human p53-speci®c primers containing sequences conserved among mammalian p53 clones. PCR was then performed in two steps; the ®rst step used a 5' primer (5'-ATGGAGGAGTCTCAGTC-3') that was degenerate at positions 10 and 12 (indicated by underlined bases) together with the oligo dT primer, while the second step used the 5' primer above and a unique 3' primer (5'-TCAGTCTGAGTCAGGCCC-3'). Ampli®cation was carried out for 30 cycles at 948C for 1 min (melting), 558C for 1 min (annealing), and at 728C for 2 min (extension). The product(s) resulting from RT/PCR were then detected by agarose gel electrophoresis and ethidium bromide staining. All primers for PCR and sequencing were made at the oligonucleotide synthesis facility at Thomas Jeerson University.
The RT/PCR products derived from each of two normal woodchuck livers were cloned into pT7Blue(R) (Novagen, Inc., Madison, WI) making a family of plasmids pT7WCp53 [a, b, etc.] . Each DNA strand in two randomly chosen clones from each liver were fully characterized by dideoxy sequencing in the nucleic acid sequencing facility at Thomas Jeerson University. For in vitro translation of woodchuck p53, the PCR products were cloned into the T cloning site of pCITE-T (Novagen) to make pCITE-WCp53 (Figure 1) . In all cases, plasmid constructs were veri®ed by sequencing prior to use in in vitro transcription and translation.
In vitro transcription, translation and characterization of WHxAg/p53 mixtures by immunoprecipitation pCITE-WCp53 and pCITE-WHx plasmids were linearized and transcribed individually or together in the Promega Riboprobe Gemini System (Promega, Madison, WI). One microgram of RNA from each of the individually transcribed plasmids and 2 mg of RNA from the reaction in which both plasmids were transcribed, were translated with [
35 S]methionine (ICN, Irvine, CA; 41000 Ci/mmole) in a 25 ml total reaction volume containing nuclease treated rabbit reticulocyte lysate according to the recommendations of the manufacturer (Promega). Incorporated radioactivity was estimated by trichloroacetic acid precipitation and counting. The translated products were then analysed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS ± PAGE) on minigels to insure that the number and size of bands corresponded to those expected from the input construct. Five to 10 ml of each reaction mixture, containing 50 000 c.p.m. of each polypeptide (1000 000 c.p.m. in cases of mixed translates), was then immunoprecipitated using 10 ml of a monoclonal antibody against X antigen (WC-9-85; an IgM) or with 1 ± 2 ml of a monoclonal antibody directed against a p53 determinant shared among human and other mammalian p53s (PAb 240, an IgG which binds to human p53 residues 212 ± 217) (Oncogene Science, Cambridge, MA). Mixtures were incubated in ice for 30 min in LASB (100 mM NaCl, 0.1 M Tris-HCl, pH 8.0 and 1% NP-40). Two microliters of Sepharose 4B conjugated recombinant protein G (Pharmacia Biotech, Piscataway, NJ) was added to the anti-p53 containing tubes, incubated for 15 min on ice, and then all immunoprecipitates were collected in an Eppendorf microcentrifuge for 20 s at maximum speed. Pellets were washed ®ve times in 1 ml of LASB buer and microcentrifuged at maximum speed for 20 s. The pellets were ®nally dissolved in 16SDS ± PAGE buer and analysed on 15% gels. The gels were then ®xed in 40% methanol and 7% acetic acid for 1 h, dried, and the bands revealed by autoradiography. c-H-ras IgG monoclonal antibody (Oncogene Research, Cambridge, MA) was used as a control for anti-p53, while a mouse IgM monoclonal antibody derived from a myeloma (Accurate Chemical Co., Westbury, NY) was used in place of WC-9-85. Synthetic peptides from the X region (peptide 100; spanning residues 116 ± 131) (Feitelson et al., 1990a) which bound WC-9-85 and from the PAb 240 binding site (woodchuck p53 sequences 210 ± 220) were made by solid phase peptide synthesis at the Jeerson Cancer Institute, and used as additional controls for immunoprecipitation. For blocking experiments, 50 mg of each synthetic peptide was preincubated with corresponding primary antibody for 1 h at 378C prior to assay.
WHxAg and p53 complex formation in transfected Hep 3B cells
The p53 null human hepatoma cell line, Hep 3B (Hosono et al., 1991) was grown in methionine minus MEM containing 10% dialyzed fetal calf serum at 378C in a 5% CO 2 atmosphere. Cells in log phase growth were transiently transfected with pcDNA3-HBx, pcDNA3-WCp53, or both using lipofectamine (GIBCO/BRL, Gaithersburg, MD). Forty-eight hours after transfection, the cells were radiolabeled with 200 mCi of [ 35 S]methionine for 2 h. The cells were then thoroughly washed, disrupted in lysis buer (20 mM Tris-HCl, pH 7.4, 2% SDS, 5 mM EGTA, 5 mM EDTA, 0.5 mM PMSF, 10 mg/ml AEBSF, 5 mg/ml leupeptin, 10 mg/ml pepstatin, 10 mg/ml TLCK and 10 mg/ml TPCK), and the lysate immunoprecipitated with anti-x (WC-9-85) or anti-p53 (PAb240). The immunoprecipitates were then analysed by SDS ± PAGE on 12.5% minigels. The gels were then dried down, and exposed by autoradiography for 5 days.
Immunoprecipitation of WHxAg and woodchuck p53 complexes from infected liver
Livers from two uninfected animals (a gift from Dr Bud Tennant) and from two or more dissected tumors and surrounding nontumor tissues from two naturally infected woodchucks were available for immunoprecipitation studies. Brie¯y, crude extracts from these tissues were prepared by Dounce homogenization, followed by differential centrifugation, exactly as described (Feitelson et al., 1993a) . Comparable amounts of protein from each sample were immunoprecipitated with either anti-p53 (PAb 240) or anti-x (Feitelson et al., 1993a; . For WHxAg detection, immunoprecipitation was carried out with monoclonal WC-9-85 or monoclonal antip53 (PAb 240) and Western blotting with a mixture of rabbit anti-x peptide antibodies , so that the heavy and light chains of the immunoprecipitating antibodies would not be detected on the blots. For woodchuck p53 detection, anti-x immunoprecipitation was carried out using polyclonal antibodies raised in rabbits against recombinant DNA produced and gel puri®ed WHxAg polypeptide (anti-rWHx), as described (Feitelson et al., 1993) . All immunoprecipitates were resolved by SDS ± PAGE on 15% gels ) and electroblotted onto Immobilon-P membranes (Millipore, Bedford, MA) . In experiments where anti-rWHx was used for immunoprecipitation, Western blotting was carried out with anti-p53 PAb 240. In either case, horseradish peroxidase conjugated antirabbit or anti-mouse-Ig was used as second antibody. The bands were revealed using the ECL detection system (Amersham) according to the instructions supplied by the manufacturer.
Database search and computer analysis
The DNA and protein sequence databases were searched using the Stringsearch, Fasta and Blast programs from the University of Wisconsin Genetics Computer Group (GCG) package. Nucleotide and amino acid sequences were aligned for homology analyses. Gaps were introduced to maximize homology. Multiple sequence alignments were performed to look for regions of conservation and variation and a consensus sequence was derived.
